Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.69
+0.28 (3.33%)
At close: May 26, 2026, 4:00 PM EDT
8.75
+0.06 (0.69%)
After-hours: May 26, 2026, 7:56 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $567.67 million as of May 26, 2026. Its market cap has increased by 23.23% in one year.
Market Cap
567.67M
Enterprise Value
604.91M
1-Year Change
23.23%
Ranking
Category
Stock Price
$8.69
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $567.67M, a decrease of -73.99%. That is a compound annual growth rate of -23.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 549.38M | 16.32% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 566.35M |
| Altimmune | 563.98M |
| Gyre Therapeutics | 553.71M |
| Tectonic Therapeutic | 549.47M |
| Assembly Biosciences | 545.58M |
| MiMedx Group | 539.18M |
| Rigel Pharmaceuticals | 536.75M |
| Prime Medicine | 536.43M |